Best Startup
At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United States based Director operating in the Medical space. If you think a Director is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Joe Rubino
R&D Director of Reckitt
Follow Joe Rubino:
About Reckitt, Reckitt: Reckitt Benckiser Group is a consumer goods company makes health, hygiene and home products.
David Sinclair
Director of Glenn Laboratories
Dr. Sinclair is a Venture Partner with Lux Capital. He is also Co-Founder of both Sirtris Pharmaceuticals (NASDAQ: SIRT) and Genocea Biosciences, and is Associate Professor of Pathology at Harvard Medical School and Director of the Glenn Laboratories for the Biological Mechanisms of Aging. He has made key contributions to the scientific understanding of aging, making him one of the most highly published and respected scientists in biology. In 1997, Dr. Sinclair identified the cause of aging in yeast, a first for any species, and in 2003 reported the discovery of a conserved master regulatory gene controlling this process. His laboratory at Harvard is currently focused on slowing diseases of aging in mammals using genetic and pharmacological means. In 2004, Dr. Sinclair co-founded Sirtris Pharmaceuticals and helped grow it into one of the most successful biotech companies in recent years. Dr. Sinclair has authored over 50 peer-reviewed scientific publications, including several seminal papers in Nature, Cell and Science. His work has been reported in most of the leading news media including the Wall Street Journal, New York Times, TIME and Newsweek. He has received numerous awards and honors for his research. Dr. Sinclair performed his post-doctoral work with Dr. Leonard Guarente at MIT and holds a Ph.D. in Biochemistry and Molecular Genetics from the University of New South Wales, Australia. Dr. Sinclair was honored by Genzyme with the Outstanding Achievement in Biomedical Science Award for 2004. Dr. Sinclair will remain an Associate Professor at Harvard Medical School and is currently a Director at Sirtris Pharmaceuticals.
Follow David Sinclair:
About Glenn Laboratories, OvaScience, Sirtris Pharmaceuticals: Glenn Laboratories is a medical research foundation focusing on the effects of aging.
Lincoln Pasquina
Associate Director, SmartTrials of Foundation Medicine
Lincoln’s first experience with the scientific method was his 7th grade science project on the effects of microwaving plant seeds before planting. (10 seconds on medium makes seeds germinate faster than untreated controls. 30 seconds cooks the seeds.) After graduating from MIT with a major in Biology, he became a graduate student in Suzanne Walker’s lab at Harvard, where he is currently studying bacterial cell wall synthesis and inhibition. He hopes to contribute to the ongoing fight against antibiotic resistance in bacteria.Are you a Harvard graduate student interested in joining our staff? Please email us at questions@emerginginvestigators.org
Follow Lincoln Pasquina:
About Foundation Medicine: Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.
Varun Gupta
IT Director, Advanced Analytics and Data Management of Mount Sinai Health System
Varun Gupta is a Technology executive with extensive IT Design, Strategy and Leadership experience in delivering business solutions to improve performance, reduce operational expenses and promote organizations growth. Focus areas include Information / Data Architecture and Strategy, Machine learning, Business Intelligence, Digital Solutions, Cloud Frameworks, Database Development and Implementation. Proficient in assisting organizations through Analytics and Digital transformations and setting up Big Data ecosystems and Advanced Analytics platforms for desired outcomes. Worked with Fortune 500 companies and has experience in leading and mentoring teams of Designers and Architects throughout the complete Software Development Life Cycle. Experienced in partnering with Data, Analytics and Digital technology vendors and Technology teams to evaluate Innovative solutions and build data infrastructure and solutions in a phased manner aligned with customers and the business needs. He is an expert in diverse Healthcare IT solution working for both Provider and Payer organizations. Proficient in leading large teams constituting Program managers, Technical Architects and Leads, database engineers and designers. Experienced in Designing state of the art Data as a service Frameworks via self-service API’s, Big Data on Hadoop ecosystem, citizen Business Intelligence solutions and Salesforce Platform. Varun has a bachelors in Computer Engineering and a Masters in Data science and Program Management from UCONN
Follow Varun Gupta:
About Mount Sinai Health System: The Mount Sinai Health System is an integrated health care system providing exceptional medical care to their local and global communities.
Lisa Chase
Senior Director of Marketing & Operations Strategy, Otolaryngology – Head , Neck Surgery of Mount Sinai Health System
Lisa Chase is the Senior Director of Marketing and Operations Strategy, Dept. of Otolaryngology at Mount Sinai Health System.
Follow Lisa Chase:
About Mount Sinai Health System: The Mount Sinai Health System is an integrated health care system providing exceptional medical care to their local and global communities.
Jonathan Dry
Director, Early Oncology of AstraZeneca
Jonathan studied Biomedical Sciences at the University of Manchester where his research focused on the genetics of diabetes, exposing him to the richness of information in DNA that can be uncovered with computational tools. He was awarded a scholarship at the University of Exeter to study Bioinformatics, where he collaborated with GlaxoSmithKline to develop computational models determining the risk of recombinant protein breakdown by proteases in host cells. In 2003 Jonathan joined AstraZeneca as the first member of the newly formed Oncology Bioinformatics team. As a scientist and senior scientist he drove adoption of ‘omic data to establish molecular line of sight for new targets, specializing in gene expression microarrays. He introduced a number of pioneering approaches harnessing gene expression data from cancer cell lines to uncover the mechanisms of pathway/drug target dependency, discovering biomarkers of drug response. Throughout his career he has supported and influenced a number of programs, including drugs targeting PARP (Lynparza), mTOR, PI3K, AKT and ERBB. His work for the MEK inhibitor selumetinib led to a transcriptional readout of MEK activity that became the first transcriptomic hypothesis tested in AZ clinical trials. As a team leader and now Director Jonathan has gone on to build a global group focused on harnessing next generation sequencing and genomic data to further AstraZeneca’s oncology drug programs and precision medicine. His team are recognized as leaders in the field, with a number of high profile publications and algorithms now adopted by leading research centers around the world such as the VarDict NGS variant caller. Jonathan carries a strong collaborative attitude and is a champion of open innovation to harness the world’s data and expertise for actionable discovery.
Follow Jonathan Dry:
About AstraZeneca: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Bruce Burlington
Non-Executive Director of AstraZeneca
Bruce Burlington is a prominent independent consultant on pharmaceutical product development and regulatory affairs with more than 30 years of experience in regulatory affairs and drug development. Bruce Burlington’s extensive experience in drug and product development comprises several senior posts at Wyeth, including Executive Vice President and Worldwide Head of Regulatory Affairs, where he played a central role in the development and global registration of many products. Prior to joining Wyeth, Bruce Burlington was a leader at the US Food and Drug Administration (FDA) where he served for 17 years in various roles, including director of the Division of Biological Investigational New Drugs, several management positions in the Center for Drug Evaluation and Research, and director of the Center for Devices and Radiological Health. As an infectious disease physician and a leader in regulatory policy, Bruce Burlington has served as the industry representative on the FDA’s Drug Safety and Risk Management Advisory Committee and currently holds Board positions at Cangene Corporation, AstraZeneca, and the International Partnership for Microbicides. Bruce Burlington graduated from Louisiana Tech University with a B.A. in Psychology and Economics and received his M.D. degree from Louisiana State University. He completed his internal medicine internship and residency, as well as his infectious disease fellowship, at the University of Colorado.
Follow Bruce Burlington:
About : AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
David Reif
Associate Director of Cancer Research of AstraZeneca
Dr. Reif serves as an Associate Director of Cancer Research at AstraZeneca. David received his B.S. in Microbiology from the University of Michigan, and his Ph.D. in 1990 in Biochemistry and Molecular Biology from Utah State University in the laboratory of Dr. Steven Aust. He completed his post-doctoral training with Dr. Roy Simmons at Fisons Pharmaceuticals (a predecessor company to AstraZeneca) in Rochester, NY. Dr. Reif then joined the staff at Fisons where he led drug discovery project teams in the areas of Parkinson’s Disease, ALS, and stroke in addition to leading the biochemistry group. In 2000, he was the first to join a new cancer discovery group within AstraZeneca at their facilities in Waltham. Dr. Reif is currently an Associate Director and Operations Manager within the cancer department and works as a member of the cancer management team in managing the portfolio of novel projects for cancer therapy. David is also intimately involved in many community outreach activities. He is a key liaison for AstraZeneca’s involvement with the New England chapter of the American Cancer Society (Making Strides Against Breast Cancer Walk and the Hope Lodge). He currently serves on the Board of Directors of the National Association of Academies of Science as well as the Massachusetts Biotechnology Education Foundation (the last four as Chairman). He also recently ended 10 yrs of service on the Lunenburg School Committee (7 total years as Chairman). Dr. Reif lives in Lunenburg, MA with his wife Trish and their three children (two in college and one in high school).
Follow David Reif:
About AstraZeneca: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Jessica Pfennig
Director of Global Digital Governance of AstraZeneca
Jessica Pfennig is Director of Global Digital Governance at AstraZenica and an impactful global leader and digital innovator with over 20 years of strategy and management experience within large pharmaceutical organizations. Jessica has advanced degrees in chemistry, information science and an EMBA. Jessica is in charge of managing and monitoring AZ’s digital asset estate. In this role she influences the future regulations for digital interactions with patients, physicians and payers. She is recognized for integrating risk avoidance and commercial compliance standards to introduce innovative technology and services. Jessica is also the Senior Global Chair for the Digital Innovators within the Healthcare Businesswomen’s Association.
Follow Jessica Pfennig:
About AstraZeneca, AstraZeneca: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Mariam Iqbal
Director Of Procurement of AstraZeneca
Follow Mariam Iqbal:
About AstraZeneca: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Neerav P. Padliya
Associate Director, Regulatory Affairs of AstraZeneca
Follow Neerav P. Padliya:
About AstraZeneca: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Eric Moskow
Chief Executive Officer, Director of Accuity Delivery Systems
Founder, CEO and Executive of several highly successful healthcare ventures; including DDDS, OBDS, and Cybear. Dr. Moskow is recognized as an innovative leader in the efficient operation of medical practices. He formed Outcome Based Delivery Systems, with operations in South Florida, Orlando, Florida and Las Vegas, Nevada, which OBDS sold in October 2011. From its founding in 2006 through the sale of its operations, OBDS built its revenue base from a run rate of $0 in 2006 to more than $80M in 2011. He formed Coral Gate Medical Group, a medical practice in Broward County, Florida, in January 2002 and has operated as its Managing Partner since inception. From 2002 to 2005, Coral Gate’s revenues increased from $350,000 to $3.5 million. From February 2000 through January 2002, Dr. Moskow served as Executive Vice President of Cybear, an information technology company serving the health care industry formed by Andrx Corp. He served as a Director of Cybear from June 1999 to 2002. From September 1996 to January 2000, Dr. Moskow was Executive Vice President of Strategic Planning for Phymatrix, a publicly-traded multi-specialty medical provider network. In addition, during this period and then through March 2002, he served as a Director of Phymatrix and its successor, Innovative Clinical Solutions, Ltd. (“ICSL”). From 1989 to 1997, Dr. Moskow served as an Internist and President of Family Medical Associates in Ridgefield, Connecticut. During part of this same period, from October 1995 to October 1996, Dr. Moskow served as Executive Vice President of Physician’s Choice Management, LLC (“PCM”), which he co-founded. In addition, from 1988 to 1992, Dr. Moskow served as Associate Medical Director in Connecticut for U.S. Healthcare. Dr. Moskow is board certified in internal medicine. He received his B.S. degree from Vassar College in 1980 and his M.D. degree from New York Medical College in 1984.
Follow Eric Moskow:
About Accuity Delivery Systems: Accuity Delivery Systems is a provider of clinical documentation services for the healthcare industry.
Donald Ehrlich
Member of the Board of Directors of Danaher
Donald Ehrlich has served on Danaher’s Board of Directors since 1985. He served as President and Chief Executive Officer of Schwab Corp., a manufacturer of fire-protective safes, files, cabinets and vault doors, from January 2003 to July 2008, and has also served on the boards of private and non-profit organizations. Donald also founded and served as the chairman and chief executive officer of an NYSE-listed, publicly-traded manufacturing company, and has also founded and served as CEO of two privately held manufacturing companies. As an entrepreneur and business leader who began his career on the factory floor, has been awarded over fifteen patents and worked his way to leadership of a large, publicly-traded company, Donald has a broad understanding of the strategic challenges and opportunities facing a publicly-traded manufacturing company such as Danaher. He also has a broad, functional skill-set in the areas of engineering, finance, capital allocation and executive compensation
Follow Donald Ehrlich:
About : Danaher is a global science and technology innovator committed to helping their customers solve complex challenges and improve quality.
Walter Lohr
Member of the Board of Directors of Danaher
Walter Lohr has served on Danaher’s Board of Directors since 1983. He was a partner of Hogan Lovells, a global law firm, for over five years until retiring in June 2012 and has also served on the boards of private and non-profit organizations. Prior to his tenure at Hogan Lovells, Walter served as assistant attorney general for the State of Maryland.He has extensive experience advising companies in a broad range of transactional matters, including mergers and acquisitions, contests for corporate control and securities offerings. His extensive knowledge of the legal strategies, issues and dynamics that pertain to mergers and acquisitions and capital raising have been a critical resource for Danaher given the importance of its acquisition program.
Follow Walter Lohr:
About : Danaher is a global science and technology innovator committed to helping their customers solve complex challenges and improve quality.
Justin Holland
Senior Director of Danaher
Follow Justin Holland:
About Danaher: Danaher is a global science and technology innovator committed to helping their customers solve complex challenges and improve quality.
Neil Poloso
Executive Director, Biological Research of Allergan
Follow Neil Poloso:
About AbbVie, Allergan: Allergan is a global pharmaceutical company.
Tory Brady
Director of Product Engineering of Allergan
Tory Brady’s passion is building software with a keen eye on the customer and the jobs they’re hiring a product to do in their lives. He loves when beautiful design, performant code and comprehensive data intersect. He’s had a fruitful career as a Software Engineer, working for a variety of technology start-ups. Now Tory is applying these learned start-up methodologies to Allergan’s medical aesthetics business as they work to revitalize the digital relationship with their consumers.
Follow Tory Brady:
About Allergan: Allergan is a global pharmaceutical company.
Vijay Raghavan
Senior Director, Management Science of Allergan
Follow Vijay Raghavan:
About Allergan: Allergan is a global pharmaceutical company.
Andrew Levin
Managing Director of RA Capital Management
Andrew Levin is a Managing Director at RA Capital Management. He is active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research tools. Prior to his current position at RA Capital, he was a Vice President at H.I.G. BioVentures and the Director of Pharmaceutical Sciences at the Clinton Health Access Initiative. He holds a BSE in Mechanical Engineering from Princeton University, a PhD in Biomedical Engineering from the Massachusetts Institute of Technology, and an MD from Harvard Medical School. His graduate thesis investigated specific and general binding in arterial drug delivery.
Follow Andrew Levin:
About Eliem Therapeutics, RA Capital Management: RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Rajeev Shah
Portfolio Manager and Managing Director of RA Capital Management
Rajeev Shah is a Partner at RA Capital Management, which has been investing in healthcare companies since 2002. Prior to joining RA Capital, Rajeev worked as a Senior Project Leader at Altus Pharmaceuticals, a spin-off company of Vertex Pharmaceuticals. At Altus, he assessed business processes and implemented system solutions for all science areas. Rajeev graduated from Cornell University, where he majored in Chemistry with a concentration in Economics. He is an active member of the Big Brothers of Massachusetts Bay program.
Follow Rajeev Shah:
About RA Capital Management: RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Joshua Resnick
Managing Director of RA Capital Management
Josh is co-founder and chief executive officer of Ataxion, and previously served on the board of CoStim Pharmaceuticals, which was sold to Novartis in February 2014. He is also an attending physician in emergency medicine at Brigham and Women’s Hospital as well as an instructor at Harvard Medical School. Prior to joining Atlas, Josh was a partner at Prism Ventures.
Follow Joshua Resnick:
About Caraway Therapeutics, RA Capital Management: RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Erich Scheller
Associate Director, Tech Atlas of RA Capital Management
Follow Erich Scheller:
About RA Capital Management, RA Capital Management: RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Amy Tenderich
Editorial Director, Diabetes & Patient Advocacy at Healthline.com of Healthline Media
Follow Amy Tenderich:
About DiabetesMine.com, DiabetesMine.com, Healthline Media: Healthline Media is the 2nd largest and fastest growing consumer health publisher in the world, reaching 85 million people a month.
Ted Miller
Board of Director of Airgas
Ted B. Miller, Jr., 75, of Gering, died Wednesday, Dec. 14, 2005, at his home. Cremation was held at Sunset Memorial Park Crematory in Scottsbluff. A memorial service will be at 10 a.m., Dec. 19, at Central Church of Christ in Gering with Pastor Herb Rainey officiating. Masonic rites will be conducted by Scotts Bluff Lodge 201 and Robert W. Furnas Lodge 265 AF & AM. A private family inurnment will be in West Lawn Cemetery in Gering with military rites by the Nebraska National Guard.
Follow Ted Miller:
About : Airgas, an Air Liquide company, is a leading U.S. single-source supplier of gases, welding equipment and supplies, and safety products.
Jordan Smith
Founder & Board of Directors of Lattis Surgical
Follow Jordan Smith:
About Lattis Surgical: The Lattis team developed a Contained Tissue Extraction (CTE) device, using bladeless technology.
Marie Auguste
Director of Materials Planning of Drive Medical
Marie Auguste joined Drive Medical in 2006 as Purchasing Manager. With over 20 years of experience in international business, Marie holds a Suny Maritime MBA in International Business and Trade. As a result of her leadership and dedication during the SAP implementation she was named Director or Materials Planning in 2009. Her primary responsibilities are not limited to but include data integrity, forecast and developing demand planning work processes in conjunction with Management & Commodity teams. Prior to joining Drive Marie held positions as a Production Manger for woven products at GAP International, and Purchasing Manager for Professional Audio products at Samson Technologies.
Follow Marie Auguste:
About Drive Medical, Premier: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Richard Burke
Non-Executive Chairman of the Board of Directors of UnitedHealth Group
Richard Burke is a Non-Executive Chairman of the Board of Directors at UnitedHealth Group.
Follow Richard Burke:
About : UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Robert Darretta
Member of the Board of Directors of UnitedHealth Group
Robert Darretta is a Member of the Board of Directors at UnitedHealth Group.
Follow Robert Darretta:
About : UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Josiane Peluso
Director, Medicare Sales and Marketing of UnitedHealth Group
Josiane Peluso is an Executive Director with a fortune 500 company. She’s been with the company for eleven years starting as a Health Education Specialist, progressively moving into different positions. Josiane received her Bachelor’s degree in Health Promotions from St. Francis College and a Masters in Community Health From Brooklyn College.
Follow Josiane Peluso:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Diane Gaswirth
Sales Director of UnitedHealth Group
Diane Gaswirth, B.S., M.S., is the sales director in San Diego county for UnitedHealthcare Medicare Solutions. She is responsible for growing membership in the Medicare portfolio of products. Prior, Diane was the sales manager for SecureHorizons/Pacificare and served in advertising, educational and service roles at Blue Cross of California. She also completed the Center of Excellence in Healthcare Management course through the University of Southern California.
Follow Diane Gaswirth:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Melanie Raslan
Senior Director, Member Analytics and Reporting of UnitedHealth Group
Melanie Raslan is Director of Marketing Analytics at UnitedHealthcare Group.
Follow Melanie Raslan:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
David Claiborn
Sr. Director, Product Design: Contact Center Services of UnitedHealth Group
Follow David Claiborn:
About UnitedHealth Group, UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Andrew Flood
Director Data Science of UnitedHealth Group
Follow Andrew Flood:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Cheri Geraffo
National Account Director of UnitedHealth Group
Cheri Geraffo is part of the UnitedHealthcare Medicare and Retirement Innovation Team. Her work is primarily focused on projects that will benefit UnitedHealthcare members and their family caregivers.
Follow Cheri Geraffo:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Mike Hanson
Director of UnitedHealth Group
Mike Hanson has many years of experience with IT leadership, having managed several different aspects of technology over the past 30 years. Today, he serves as global operations manager and leads the asset management and fulfillment teams for Optum, Inc. He has been involved with HDI for many years, as both a local chapter officer and as a past chair of the HDI Desktop Support Advisory Board.
Follow Mike Hanson:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Cheri Geraffo
National Account Director of UnitedHealth Group
Cheri Geraffo is part of the UnitedHealthcare Medicare and Retirement Innovation Team. Her work is primarily focused on projects that will benefit UnitedHealthcare members and their family caregivers.
Follow Cheri Geraffo:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Mike Hanson
Director of UnitedHealth Group
Mike Hanson has many years of experience with IT leadership, having managed several different aspects of technology over the past 30 years. Today, he serves as global operations manager and leads the asset management and fulfillment teams for Optum, Inc. He has been involved with HDI for many years, as both a local chapter officer and as a past chair of the HDI Desktop Support Advisory Board.
Follow Mike Hanson:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Scott Marshall
Managing Director of Precision Analytics of Precision for Medicine
Scott Marshall is the Managing Director, Provide Technology Driven Biomarker Data Integration & Computational Biology at QuartzBio.
Follow Scott Marshall:
About Precision for Medicine, Quartz Bio: Precision for Medicine is a specialized scientific services company helping life science innovators develop medical products.
Daniel Birtwhistle
Senior Director Product Development Security of GE Healthcare
Follow Daniel Birtwhistle:
About GE Healthcare: GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care.
Anaf Durrani
Senior Director of Cigna
Anaf Durrani has been with Cigna since 2013 and is currently responsible for leading the DevOps and Productivity Engineering Center of Enablement and the Software Defined Everything (SDx) initiative for Global Infrastructure Services. In this role, Anaf drives DevOps architecture, engineering, and enablement working across 500 scrum teams. As the SDx lead, Anaf is bringing a software engineering mindset to infrastructure to enable Cigna to support a hybrid, multi-cloud environment. Anaf started his career at Motorola in the Push-to-Talk (PPT) division as an engineer. He was part of a team that expanded PTT globally. Prior to Cigna, Anaf spent 6 years at Orbitz.com and its online retail travel brands leading Product Development and Quality Engineering organizations transitioning his teams to practice continuous delivery. Anaf has worked in the business and IT with a primary focus on enhancing customer experience. His experience with start-ups and enterprise development provides a unique experience to enable transitions. Anaf has earned a master’s in software engineering from Southern Methodist University, a bachelor’s in computer science from DePaul University and currently resides in Schaumburg, IL with his wife, 3 sons and 2 daughters.
Follow Anaf Durrani:
About Cigna: CIGNA Corporation operates as a health service company that helps people to improve the health, well-being, and peace of mind.
James Rogers
Member of the Board of Directors of Cigna
James Rogers is Chairman of the Board of Directors at Duke Energy. Prior to being elected Chairman of the Board of Directors in January 2007, James also served as Duke Energy’s President and Chief Executive Officer from April 2006 until his retirement on July 1, 2013. Rogers served as a Chief Executive Officer in the utility industry for 25 years. Over that period, James delivered an average total shareholder return of more than 12 percent per year by focusing on sustainable growth and executing a series of well-timed mergers, acquisitions and divestitures. In 2013, James was awarded the Edison Electric Institute’s Distinguished Leadership Award by his industry peers in recognition of his 25 years of service and exemplary contributions to the electric utility industry. In addition, the Alliance to Save Energy honored Rogers with its Lifetime Achievement Award. James became President and Chief Executive Officer at Duke Energy following the merger between Duke Energy and Cinergy in 2006. Before the merger, James served as Cinergy’s Chairman of the Board of Directors and Chief Executive Officer for more than 11 years. Prior to the formation of Cinergy, James joined PSI Energy in 1988 as the company’s Chairman of the Board of Directors, President and Chief Executive Officer. James has served as Deputy General Counsel for Litigation and Enforcement for the Federal Energy Regulatory Commission (FERC); Executive Vice President of Interstate Pipelines for the Enron Gas Pipeline Group; and as a Partner in the Washington, D.C., law office of Akin Gump Strauss Hauer & Feld. Prior to those appointments, James served as Assistant to the Chief Trial Counsel at FERC; as a Law Clerk for the Supreme Court of Kentucky; and as Assistant Attorney General for the Commonwealth of Kentucky, where he advocated for the state’s consumers in gas, electric and telephone rate cases. James was also a Reporter for the Lexington (Kentucky) Herald-Leader for three years. In the course of his career, James has served on the boards of directors of eight Fortune 500 companies and is currently a Member of the Board of Directors at Cigna Corp. and Applied Materials Inc. In 2010 and 2011, James was named by the National Association of Corporate Directors’ Directorship magazine to its annual Directorship 100, recognizing the most influential people in corporate governance. Also during his career, he has owned and/or operated assets in 17 countries in Africa, South Asia, Europe, and Central and Latin America. Born in 1947 in Birmingham, Ala., James grew up in Kentucky. James attended Emory University and earned Bachelor of Business Administration and Juris Doctor degrees from the University of Kentucky, where he was a Member of the Kentucky Law Journal and Beta Gamma Sigma National Honor Society. James was named to the Hall of Fame at the Carol Martin Gatton College of Business and Economics and the Hall of Fame at the College of Law, both at the University of Kentucky. James was inducted into the University of Kentucky’s 2010 Hall of Distinguished Alumni. James has also been awarded Honorary Doctorate degrees from four universities. James and his wife, Mary Anne, have two daughters, a son and 11 grandchildren.
Follow James Rogers:
About : CIGNA Corporation operates as a health service company that helps people to improve the health, well-being, and peace of mind.
Ian Van Every
Co-Founder & UK Managing Director of Lemonaid Health
Follow Ian Van Every:
About Lemonaid Health: Lemonaid Health is a telemedicine platform that uses technology to change the way people interact with health care.
Daniel Grau
President, Chief Executive Officer, and Director of Sojournix
Grau co-founded and has served as Chief Executive Officer and Director at Sojournix since 2016. An experienced biotech entrepreneur and operating executive, Mr. Grau led the deal to acquire SJX-653 and has driven the rapid growth and financing of the company from startup to clinical-stage pharmaceutical business. Prior to Sojournix, Mr. Grau served as President at Heptares Therapeutics (acquired 2015), Chief Executive Officer at Cortria (acquired 2010), and Chief Operating Officer at CombinatoRx (IPO 2005). Mr. Grau currently serves as an advisor to HotSpot Therapeutics and previously served as a member of the Product Advisory Board at Concert Pharmaceuticals and as an advisor to Nimbus Therapeutics. Earlier in his career, Mr. Grau worked with multi-national pharma companies as a management consultant focused on corporate and business franchise strategy, M&A, and new product launches. Mr. Grau earned his M.Phil., M.A., and M.A.R. degrees from Yale University, where he was awarded a Mellon Fellowship, the Day Graduate Prize, and a Bass Fellowship, and a B.A. with High Honors from Davidson College, where he held a Dana Honor Scholarship, a Montgomery Scholarship, and was elected to Phi Beta Kappa.
Follow Daniel Grau:
About Cortria Corporation, Heptares Therapeutics, Sojournix: Sojournix is a biotechnology company developing innovative medicines for women’s health and endocrine disorders.
Carson Pickens
Executive Director, Product Management of Aetna
Carson Pickens is the Executive Director of Digital Product Management at Aetna, a CVS Health Company. In this capacity, he and his team are responsible for the consumer facing assets that Aetna puts in the hands of its members. Prior to joining CVS Health, Carson was the Chief Product Officer at HealthEngine, a Chicago based start-up focused on reducing healthcare costs for patients. Earlier in his career, Carson was an early employee at bswift, a benefit administration and enrollment company acquired by Aetna in 2014. At bswift, he served in a number of leadership roles in operations and product management.
Follow Carson Pickens:
About Aetna: Aetna a diversified health care benefits company, provides individuals and many others with innovative benefits, products, and services.
Aleksandar Lazarevic
Senior Director of Aetna
Aleksandar is responsible for overall predictive analytics solution in health care fraud initiative at Aetna. In addition to health care industry, he has extensive experience in various data analytics projects ranging from banking, credit and insurance industry to diagnostics and computer security applications. He has co-edited a book on cyber security threats, written 8 book chapters and published over 50 research articles, which were cited more than 3,000 times. He holds a PhD degree in data mining / machine learning from Temple University. He had been frequently giving presentations at predictive analytics / data mining conferences in the past.
Follow Aleksandar Lazarevic:
About Aetna: Aetna a diversified health care benefits company, provides individuals and many others with innovative benefits, products, and services.
Kristie Parr
Executive Director, Marketing Technology and Digital Operations of Aetna
Follow Kristie Parr:
About Aetna, Aetna: Aetna a diversified health care benefits company, provides individuals and many others with innovative benefits, products, and services.
Donovan Pepper
National Director, Local Goverment Relations of Walgreens
Donovan is the National Director of Local Government Relations for Walgreen Co. Prior to this position, Donovan served as the Director of Government Relations for the Illinois Restaurant Association. He has worked for SBC, the Chicagoland Chamber of Commerce, and served on the Appropriations in Political Studies from Univ. of Illinois-Springfield and a Bachelor’s in Political Science from Sangamon State.
Follow Donovan Pepper:
About Walgreens: Walgreens provides multi-channel access to consumer goods and cost-effective pharmacy, health, and wellness services.
Abey Koshy
Director of Data & Corporate Technologies ,Principal Architect of Walgreens
Abey Koshy is the Director of Data & Corporate Technologies ,Principal Architect at Walgreens.
Follow Abey Koshy:
About Walgreens, Walgreens: Walgreens provides multi-channel access to consumer goods and cost-effective pharmacy, health, and wellness services.
Kurt Erchinger
Sr. Director, Online Technology, Digital Engineering & Mobile Solutions of Walgreens
Kurt Erchinger is the Sr. Director, Online Technology, Digital Engineering & Mobile Solutions at Walgreens.
Follow Kurt Erchinger:
About Walgreens: Walgreens provides multi-channel access to consumer goods and cost-effective pharmacy, health, and wellness services.
Kurt Erchinger
Sr. Director, Online Technology, Digital Engineering & Mobile Solutions of Walgreens
Kurt Erchinger is the Sr. Director, Online Technology, Digital Engineering & Mobile Solutions at Walgreens.
Follow Kurt Erchinger:
About Walgreens: Walgreens provides multi-channel access to consumer goods and cost-effective pharmacy, health, and wellness services.
Maren Ohaks Katzaroff
Director – Strategic Planning of Vivos Inc
Maren drives the commercialization of AMI’s brachytherapy products including operational and regulatory aspects through strategic initiatives. Maren has extensive expertise in global commercialization strategies, operations, strategic planning and regulatory compliance in a variety of sectors including medical device, biotechnology, academia and banking. Maren has been instrumental in preparing device and drug products for FDA review including quality system establishment, manufacturing oversight, preparation of FDA filings and participation in FDA reviews. Prior to joining AMI, Maren was employed by the University of Washington (UW) to create and run programs to facilitate engagement between industry and UW researchers and students to foster commercialization of UW technology. This included opening and running the first UW managed high tech incubator. In addition, Maren has held key strategic and operational roles for a number of medical device and biotechnology companies including Amgen and several Seattle area start-ups. She earned an MBA with an emphasis in Management and Technology, and a BS in Cell and Molecular Biology with a minor in Chemistry, both from the UW. Maren enjoys active roles in numerous community organizations.
Follow Maren Ohaks Katzaroff:
About Vivos Inc: Vivos Inc develops manufacturing equipments for the production of medical isotopes used in diagnosis and treatment of diseases.
Donald A. Ludwig
Director of Special Projects of Vivos Inc
Donald A. Ludwig, PhD., is Director of Special Projects for AMI. As an expert in particle accelerator applications in radiation therapy, nuclear medicine and radioisotope production Dr. Ludwig also serves as an advisor to numerous entities in the field, both domestic and foreign. Among these are the Atomic Energy of Canada, the U. S. Department of Energy Labs at Los Alamos, Berkeley, Fermi, Hanford and Oak Ridge, the Israel Atomic Energy Agency, the Australian Nuclear Science and Technology Organization, the Budker Institute of Nuclear Physics in Novosibirsk, Siberia, the Malaysian Institute of Nuclear Technology and the Bhabha Atomic Research Center in Mumbai, India. He holds advanced degrees in nuclear physics, medical physics and marketing from top tier Universities. Dr. Ludwig’s endeavors for AMIC are focused on facilitating the return of clinical radioisotope production to the US, and aiding AMIC in becoming the largest provider of radioisotopes in North America.
Follow Donald A. Ludwig:
About Vivos Inc: Vivos Inc develops manufacturing equipments for the production of medical isotopes used in diagnosis and treatment of diseases.
Bret Henning
Sr Director and Information Technology of Tandem Diabetes Care
Bret Henning is currently the Sr. Director of Information Technology at Tandem Diabetes Care, Inc. Bret is responsible for worldwide IT operations including infrastructure, cloud computing, collaboration technologies, enterprise applications, DEVOPS, call center and voice technologies. At Tandem Bret was involved in building the company from an early stage startup through product commercialization. He brings a diverse portfolio of experience managing everything from Facilities to Connected Heath. His background includes more than 30 years of hands-on experience in technology for electronics and medical device companies.
Follow Bret Henning:
About Tandem Diabetes Care: Tandem Diabetes Care develops medical devices for the treatment of diabetes offering diabetic insulin pumps for adults and children.
Caleb Winder
Managing Director of Excel Venture Management
Caleb Winder is a venture capitalist who focused on life sciences, healthcare and information technology. He is currently a Managing Director at Excel Venture Management & at the MemorialCare Innovation Fund Caleb has a broad set of experiences from his early career in sales and marketing at small and medium sized companies in the diagnostics and medical capital equipment business and from his work in marketing, business development, and finance at various startups. Caleb currently serves on the boards of ClearDATA, Aileron Therapeutics, InfoBionic, WellDoc, Ayogo Health, and Qstream. He formerly served on the boards at Cleveland Heartlab, MedVentive, Saladax, ShapeUp, Oculus Health, Aventura, and Xcellerex
Follow Caleb Winder:
About AristaMD, Excel Venture Management, Excel Venture Management, Foldax, Laudio, LeanTaaS, MemorialCare Innovation Fund, Olive, Phynd Technologies, Xealth: Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond.
Juan Enriquez
Managing Director of Excel Venture Management
Juan Enriquez is a Managing Director at Excel Venture Management. He is a leading authority on the economic impact of life sciences on business and society, and a respected business leader and entrepreneur. He represents Excel on the boards of Shape Up the Nation, Fina Technologies, Catch.com, and Synthetic Genomics, as well as Activate Networks. Prior to Excel, Enriquez was the Founding Director of the Harvard Business School’s Life Sciences Project, with many of his innovative thoughts captured in his bestselling book, As the Future Catches You, which provides an accurate blueprint of how a bio-based economy changes industries and corporations. Following HBS, Enriquez became an active angel investor and founder of Biotechonomy Ventures, which invested in BioTrove, Xcellerex, and Synthetic Genomics, a company he co-founded with Drs. J. Craig Venter and Hamilton Smith, to apply life sciences to energy markets. As a business leader, advisor, and renowned speaker, he works directly with the CEOs of a number of Fortune Fifty companies, as well as with various heads of state, on how to adapt to a world where the dominant language is shifting from digital towards the language of life. He is a member of the Board of Directors of Cabot Corporation (NYSE: CBT), and he graduated from Harvard with a B.A. and M.B.A., both with honors.
Follow Juan Enriquez:
About Biotechonomy, Excel Venture Management, Viridos: Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond.
Rick Blume
Managing Director of Excel Venture Management
Rick Blume has been financing companies in healthcare for over three decades. His early investment banking career involved financing and banking relationships with hospitals, payers, physicians, and new biotech companies. The excitement he saw at Genentech, in its early years, led him to transition into venture capital in the mid 1980’s. Rick co-founded CB Health Ventures in 1998 where he assembled what is now the core of Excel including Enrico Petrillo, M.D., Steve Gullans, PhD, and Tricia Moriarty. Rick has served as a director or active investor in many companies including Lantos Technologies, Cytyc (acquired by Hologic – HOLX), AbT (now OSI – OSIP), Somatogen (acquired by Baxter – BAX), EdenTec (acquired by Nellcor), Exact Sciences (EXAS), IPC The Hospitalist Company (IPCM), GeneOhm (acquired by Becton Dickinson – BDX), Zonare, TransMedics, US Servis (acquired by McKesson); and the former public health insurance company Washington National. In addition to Excel, Rick has been active in initiating and teaching courses in venture capital and entrepreneurship at both Boston College Carroll School of Management and Simmons College School of Management, and serving on the Boards of the Chicago Biomedical Consortium and the National Regenerative Medicine Foundation .Rick did his undergraduate studies at University of the Pacific and Stanford. His MBA is from Stanford University.
Follow Rick Blume:
About CB Health Ventures, Excel Venture Management, GeneOhm Sciences, Zonare Medical Systems: Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond.
Lloyd Ratner
Professor of Surgery; Director, Renal & Pancreatic Transplantation of Columbia University
Lloyd Ratner, M.D., M.P.H., is professor of surgery and director of renal and pancreatic transplantation at Columbia University/NY Presbyterian Hospital in New York. He has served as a member of the membership and professional standards committee and its performance analysis and improvement subcommittee. He also was a member of the kidney paired donation workgroup and previously served on the kidney transplantation committee. Dr. Ratner serves on the council (board of directors) and the living donor committee of the American Society of Transplant Surgeons (ASTS). He also is chair of the board of directors of New York Organ Donor Network and a member of its critical care working group, previously serving as chair of the medical advisory board. He was a member of the ASTS/American Society of Transplantation/NATCO joint societies workgroup on living kidney donor policy. He has served on the medical advisory board of Gift of Life Donor Program and the National Kidney Foundation of Maryland and on the board of directors of the Transplant Resource Center of Maryland (now, the Living Legacy Foundation). He earned his medical degree at Hahnemann University School of Medicine in Philadelphia and a master’s degree of public health from Columbia University in New York.
Follow Lloyd Ratner:
About Columbia University, the American Society of Transplant Surgeons: Columbia University is one of the centers of research and a distinctive and distinguished learning environment.
Brady Jensen
Senior Director & Head of Global Human Resource Operations of Willis Towers Watson
Follow Brady Jensen:
About Willis Towers Watson: Willis Towers Watson is a global advisory and solutions company that helps clients around the world turn risk into a path for growth.
Claudia Piccirilli
Product Director, Cyber Analytics of Willis Towers Watson
Follow Claudia Piccirilli:
About Willis Towers Watson: Willis Towers Watson is a global advisory and solutions company that helps clients around the world turn risk into a path for growth.
Linda Rabbitt
Board of Director of Willis Towers Watson
Follow Linda Rabbitt:
About : Willis Towers Watson is a global advisory and solutions company that helps clients around the world turn risk into a path for growth.
Ravin Jesuthasan
Managing Director of Willis Towers Watson
Ravin Jesuthasan is a recognized global thought leader and author on the future of work and human capital. He has led numerous research efforts on the global workforce, the emerging digital economy, the rise of artificial intelligence, and the transformation of work. He has also led research projects for the World Economic Forum, including its ground-breaking study “Shaping the Future Implications of Digital Media for Society” and the recently launched “Creating a Shared Vision for Talent in the 4th Industrial Revolution.” He is a regular participant and presenter at the World Economic Forum’s annual meetings in Davos and Dalian/Tianjin and is a member of the forum’s Steering Committee on Work and Employment. He has been recognized as one of the top 25 most influential consultants in the world by Consulting magazine. He is the author of “Transformative HR, Lead The Work: Navigating a World Beyond Employment,” and “Reinventing Jobs: A 4-Step Approach to Applying Automation to Work.”
Follow Ravin Jesuthasan:
About Willis Towers Watson: Willis Towers Watson is a global advisory and solutions company that helps clients around the world turn risk into a path for growth.
Chris Keys
Director, HR Software of Willis Towers Watson
Follow Chris Keys:
About Willis Towers Watson: Willis Towers Watson is a global advisory and solutions company that helps clients around the world turn risk into a path for growth.
Stanley Lapidus
Board of Directors of Daktari Diagnostics
He is an experienced entrepreneur. He founded and served as CEO of three public companies, Cytyc, EXACT Sciences, and Helicos BioSciences. He currently serves as CEO of SynapDx Corp., which he founded in 2009 to develop novel diagnostics for autism. He teaches at the Biomedical Enterprise Program at MIT and is the inventor of 31 US patents.
Follow Stanley Lapidus:
About University of Colorado Anschutz Medical Campus: Daktari Diagnostics manufactures diagnostic medical products for clinicians and patients.
Ed Hammond
Director of Clinical Programs of Domain Surgical
Ed Hammond is the Director, Clinical Programs at OmniGuide.
Follow Ed Hammond:
About Domain Surgical, OmniGuide: Domain Surgical creates energy-based surgical products for precise soft tissue cutting and coagulation.
Johannes Fruehauf
Founder, President & Executive Director of LabCentral
Johannes Fruehauf is the Founder & CEO LabCentral/Biolabs.He is responsible for all aspects of LabCentral’s operation. Johannes is a physician and successful biotech entrepreneur. Prior to LabCentral, he founded Cambridge Biolabs, a contract research facility serving startup and virtual companies in Kendall Square. He is also a co-founder of ViThera Pharmaceuticals, Deltix and Cequent Pharmaceuticals, and an advisor or board member to numerous life sciences companies and non-profits. Johannes earned his medical degree at the University of Frankfurt and his PhD at the University of Heidelberg (Germany).
Follow Johannes Fruehauf:
About Arkuda Therapeutics, BioLabs, Cequent Pharmaceuticals, Deltix, LabCentral, Mission BioCapital: LabCentral developing novel cancer treatments: Conkwest, Inc, headquartered in DelMar, California, is opening its research laboratory at
Robert Carruthers
Senior Director, Talent Acquisition Operations of Celgene
Robert Carruthers works at Celgene corporation as part of their Talent Acquisition Leadership team, and with the implementation of his ‘Total Talent Solution’ Operations model, has helped propel the transformation of how talent is acquired at this global biopharmaceutical leader. He, and his team of associates and partners, are responsible for the technologies, processes, resourcing and analytics strategies that enable both the employee and contingent workforces of the organization.
Follow Robert Carruthers:
About Celgene: Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.
Thomas Scalone
Director North American Logistics of Celgene
Follow Thomas Scalone:
About Celgene: Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.
Roy Paul
Associate Director of Celgene
Follow Roy Paul:
About Celgene: Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.
Jeffrey Gatz
Director of BioIVT
Jeffrey Gatz is the director at BioIVT.
Follow Jeffrey Gatz:
About : BioIVT is a worldwide provider of biological and in vitro products to pharmaceutical and biotechnology organizations
Alex Milligan
Co-founder & Marketing Director of Nugg
Follow Alex Milligan:
About Nugg: Nugg allows mmj patients to find and order cannabis-based products from nearby collectives that deliver or offer pickup.
Michael Bartholomew
Co-Founder, Inside Director & Chief Commercial Officer of Promaxo
Mr. Michael Bartholomew is the EVP and Chief Commercial Officer at Promaxo. He has broad therapeutic experience across nearly twenty diseases covering large and small molecules, medical devices and diagnostics. Michael manages the go to market strategy, voice of customer, partner relationships and tactical implementation relating to corporate infrastructure. Prior to Promaxo, Michael was a Principal at Porzio Life Sciences, as well as Vice President of Sales & Marketing for Dohmen Life Science Service, where he developed and launched several commercial initiatives achieving sustained sales growth. Before Dohmen, he served in various sales and brand leadership positions for Pfizer, Pharmacia and Baxter. Michael proudly served in the US Air Force as a decorated combat aviator, where he achieved the rank of Captain. He received his Masters of Science in Administration from Central Michigan University and his Bachelor of Arts in Economics from Indiana University.
Follow Michael Bartholomew:
About Neuro42, Promaxo: Promaxo is commercializing customer-centric MRI systems and robotic guidance tools for live diagnosis and treatment in a physician’s office.
Nicolas Sauvage
Managing Director of TDK Ventures
Managing Director of TDK Ventures. TDK Ventures is a technology-focused venture fund, investing globally in early-stage startups that leverages fundamental material science to unlock an attractive and sustainable future for the world. TDK Ventures goal is to help every start-up we invest to achieve their full potential for positive world impact. He was previously responsible at InvenSense for all strategic ecosystem relationships, including Google and Qualcomm, and other HW/SW/System companies. Before that, Nicolas was part of NXP Software management team, responsible for worldwide sales, and later P&L and product management of the OEM Business Line. Nicolas is an alumnus of Stanford, INSEAD, Institut supérieur d’électronique et du numérique and London Business School
Follow Nicolas Sauvage:
About TDK Corporation, TDK Ventures, TDK Ventures: TDK Ventures is the Corporate VC arm of TDK Corporations that invests globally in hard-tech entrepreneurs.
Bray Patrick-Lake
Director, Strategic Partnerships of Evidation Health
Bray is the Director of Strategic Partnerships at Evidation Health. She develops collaborations to support the design and implementation of participant-centered studies, and serves on the All of Us National Advisory Panel, the Digital Medicine Society Scientific Leadership Board, and the National Academies of Sciences, Engineering, and Medicine (NASEM) Health Science Policy Board. Previously, Bray led engagement for the Duke Clinical Research Institute Project Baseline Study Coordinating Center and served as co-chair on the Advisory Committee to the NIH Director that authored the Precision Medicine Initiative’s Cohort Program. Bray holds a BS degree from the University of Georgia, and an MFS degree from National University.
Follow Bray Patrick-Lake:
About Evidation Health: We enable and empower everyone to participate in better health outcomes.
David Casey
President, Board of Directors of CVSHealth
David Casey serves as Vice President, Workforce Strategies and Chief Diversity Officer for CVS Health. Casey joined the company in 2010 and is responsible for developing and driving diversity and engagement strategies across the company. He is also focused on ensuring that diversity and inclusion are embedded in CVS Health’s recruitment, talent development, performance management and succession planning efforts. In prior roles, Casey was Chief Diversity Officer at WellPoint, where he led the development and execution of enterprise-wide strategies to leverage diversity management for the workforce, workplace and marketplace. Casey was also a Regional Director of Business Development for Bernard Hodes Group, where he consulted with regional, national and international clients. Casey is a veteran of the United States Marine Corps and served in Operation Desert Storm. Casey has a Bachelor of Science degree in business administration from Indiana Wesleyan University.
Follow David Casey:
About CVSHealth: CVS Health provides an integrated healthcare services offering for its members.
Vijay Patel
Senior Director Strategic Partnerships of CVSHealth
Vijay Jun Patel is the Co-Founder & Partner CVS Health Ventures.
Follow Vijay Patel:
About CVSHealth, CVSHealth: CVS Health provides an integrated healthcare services offering for its members.
Nels Lindahl
Director, Clinical Decision Systems of CVSHealth
Nels Lindahl is the Director of Clinical Decision Systems at CVS Health.
Follow Nels Lindahl:
About CVSHealth: CVS Health provides an integrated healthcare services offering for its members.
Kerry Noone
Director, Employer Branding and Recruitment Marketing of CVSHealth
Kerry Noone is the Director of Employer Branding and Recruitment Marketing at CVS Health.
Follow Kerry Noone:
About CVSHealth: CVS Health provides an integrated healthcare services offering for its members.
Michael Tew
CSO, Director of Red Mind Solutions, Inc.
Michael Tew has over 14 years’ experience in corporate finance, venture capital, business management, and capital markets. From 1999 until September 2003, Mr. Tew was an analyst and vice president in the hospitality and leisure group at Bear, Stearns, & Co., Inc. Since that time, he has acted as founder, advisor, or executive focused on standing up operations at early- and middle-market operating companies with a transaction oriented mandate. His experience includes time at technology companies such as Reputation.com, Tinga Airex, Inc., and Red Mind Solutions, Inc. among others. He is also an expert in special purpose acquisition companies. Mr. Tew has a degree in finance and international business from New York University Stern School of Business and has an executive MBA from the same.
Follow Michael Tew:
About CannaSys, Red Mind Solutions, Inc.: Proven Defense & Space Technologies for Improved Healthcare Intervention Services
Jeff Critser
Director of Red Mind Solutions, Inc.
Follow Jeff Critser:
About : Proven Defense & Space Technologies for Improved Healthcare Intervention Services
Jeff Critser
Director of Red Mind Solutions, Inc.
Follow Jeff Critser:
About : Proven Defense & Space Technologies for Improved Healthcare Intervention Services
Milan Thakor
Director of Product of Blink Health
Milan Thakor is the director of product at Blink Health. He is a product and growth marketing leader with deep experience building early and growth stage companies.
Follow Milan Thakor:
About Blink Health: Blink Health is a web-based application that enables users to search for medical prescriptions online and pick them up from any pharmacy.
Joseph Authement
US Director Strategic Accounts-Robotics and Digital Solutions of Johnson & Johnson
Follow Joseph Authement:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Alice Lin Fabiano
Global Director of Social Innovation & Investment, Global Community Impact of Johnson & Johnson
Alice Lin Fabiano is a Global Director at Johnson & Johnson, Global Community Impact. In this capacity, she leads its social innovation strategy and investments in the discovery, engagement, and celebration of purpose driven entrepreneurs, with a focus in health technology and impact investing.
Follow Alice Lin Fabiano:
About Johnson & Johnson, Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Daniel Watts
Director, Global Process Owner, Global Contracting Solutions of Johnson & Johnson
Follow Daniel Watts:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Hari Kamaraju
Director and Head of Manufacturing Excellence, Advanced Therapies of Johnson & Johnson
Follow Hari Kamaraju:
About Janssen Belgium, Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Bret Evans
Sr Director IT of Johnson & Johnson
Currently Bret is the Sr. Director of IT Supply Chain for Johnson & Johnson Ethicon & CSS business.
Follow Bret Evans:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Rick Desmarais
Director Global JJOS Deployment Leader of Johnson & Johnson
Follow Rick Desmarais:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Joy Marini
Director of Corporate Contributions of Johnson & Johnson
Joy Marini became Director of Corporate Contributions in 2007, following 6 years with the Johnson & Johnson Pediatric Institute. Joy is responsible for Johnson & Johnson’s international programs on maternal and infant health, gender-based violence and gender inequality, and economic empowerment of women. She has been instrumental in developing sustainable partnership initiatives, most notably for her efforts on a Neonatal Resuscitation Program (NRP) in China — a 5-year collaboration between the Chinese Ministry of Health, the American Academy of Pediatrics (AAP), several Chinese health-professional organizations, and Johnson & Johnson, which reduced neonatal mortality by 54% in over 300 measured hospitals. Joy has contributed to the development of publications for parents and health professionals, including the Compendium of Postpartum Care with the Association of Women’s Health, Obstetrics and Neonatal Nursing, and Eating Behaviors of the Young Child with the AAP. Joy earned her MS Physician Assistant from the University of Medicine and Dentistry of New Jersey in 1997. She received an MBA from Rider University.
Follow Joy Marini:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Ravi Bhatia
Scientific Director of Johnson & Johnson
Follow Ravi Bhatia:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Reggie Fortson
Director of Product Lifecycle Management (PLM) of Johnson & Johnson
Follow Reggie Fortson:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Susan Can
Senior Director & Global Corporate Brand and Corporate Affairs of Johnson & Johnson
Follow Susan Can:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Susan Can
Senior Director & Global Corporate Brand and Corporate Affairs of Johnson & Johnson
Follow Susan Can:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Gregory Smith
IT Director, I&AM Engineering of Johnson & Johnson
Follow Gregory Smith:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Gillian Hanson
Director, Data & Informatics of PicnicHealth
Follow Gillian Hanson:
About PicnicHealth: PicnicHealth helps patients easily access their medical records and gives them the opportunity to contribute data to medical research.
Ping Gao
Center Director of Abbott
Follow Ping Gao:
About Abbott: Abbott is engaged in pharmaceuticals and manufacturing healthcare products.
Caroline Leab
Director, R&D of Abbott
Caroline Leab is a Director of Regulatory Affairs for Abbott, formerly St. Jude Medical. Caroline leads the EU MDR Implementation Program and Clinical Evaluation Process for the Abbott Cardiovascular and Neuromodulation organization. She has a background in Manufacturing and Quality Engineering with companies such as Boston Scientific and Nestle Healthcare Nutrition. Caroline led Quality organizations for AGA Medical and Monteris Medical before joining St. Jude Medical as a Director of R&D in 2014. Caroline serves on the Board of Directors for The Bakken Museum in Minneapolis and participates on various MDIC and AdvaMed committees.
Follow Caroline Leab:
About Abbott: Abbott is engaged in pharmaceuticals and manufacturing healthcare products.
David Silbersweig
Chairman, Dept of Psychiatry; Co-Director, Center for the Neurosciences of Brigham and Women’s Hospital
David Silbersweig, MD, is one of the pioneers of functional neuroimaging research in psychiatry. The aim of his current work in systems-level neuropathophysiology is to help provide a foundation for the development of novel, targeted, and biologically based diagnostic and therapeutic strategies to aid those suffering with mental illness. Dr. Silbersweig is now the Chairman of the Department of Psychiatry at the Brigham and Women’s/Faulkner Hospitals, and Chairman of the Brigham and Women’s Hospital Institute for the Neurosciences. He also is Stanley Cobb Professor of Psychiatry at Harvard Medical School.
Follow David Silbersweig:
About Brigham and Women’s Hospital: Brigham and Women’s Hospital is an academic medical center based in Boston, Massachusetts.
Antonio Chiocca
Director of Brigham and Women’s Hospital
Dr. Chiocca is a world-renowned physician-scientist, whose clinical and scientific expertise revolves around the surgical/medical treatment of human brain tumors and understanding their biology and applying novel therapeutics to their treatment, including those that are viral-based. In this respect, his research laboratory has provided several contributions to the utilization of oncolytic viruses in tumor therapy. In addition, Dr. Chiocca’s laboratory has active programs in microRNA biology and drug discovery. Dr. Chiocca has trained numerous postdoctoral fellows, students and mentored junior faculty. In addition to this he has been the local and national PI of several clinical trials using gene- and virus-based therapies for malignant glioma.
Follow Antonio Chiocca:
About Brigham and Women’s Hospital, Harvard Medical School: Brigham and Women’s Hospital is an academic medical center based in Boston, Massachusetts.
Antonio Chiocca
Director of Brigham and Women’s Hospital
Dr. Chiocca is a world-renowned physician-scientist, whose clinical and scientific expertise revolves around the surgical/medical treatment of human brain tumors and understanding their biology and applying novel therapeutics to their treatment, including those that are viral-based. In this respect, his research laboratory has provided several contributions to the utilization of oncolytic viruses in tumor therapy. In addition, Dr. Chiocca’s laboratory has active programs in microRNA biology and drug discovery. Dr. Chiocca has trained numerous postdoctoral fellows, students and mentored junior faculty. In addition to this he has been the local and national PI of several clinical trials using gene- and virus-based therapies for malignant glioma.
Follow Antonio Chiocca:
About Brigham and Women’s Hospital, Harvard Medical School: Brigham and Women’s Hospital is an academic medical center based in Boston, Massachusetts.
Cliff Sirlin
Managing Director of LaunchCapital
Cliff Sirlin is a career entrepreneur who has founded and operates a portfolio of high growth businesses. Cliff is also an active Angel Investor. Cliff received his law degree from New York University School of Law. While at NYU, Cliff also studied at the Stern School of Business. He earned his BA in History from Colgate University. Cliff’s accomplishments have been profiled by CNBC; Inc. Magazine; Success Magazine; and Crain’s Business. Cliff also is a frequent lecturer at the NYU Stern School of Business.
Follow Cliff Sirlin:
About LaunchCapital, NYU Stern School of Business: LaunchCapital was founded in January 2008 with a mission to help entrepreneurs gain quick access to seed capital and mentorship.
Elon Boms
Founder, Board of Directors of LaunchCapital
Elon Boms co-founded LaunchCapital in January 2008 to help entrepreneurs gain quick access to seed capital and mentorship. With a passion for working with industry disruptors and teams that have a strong business development focus, Elon has been involved in over 75 deals across a wide range of industries and geographies. He holds an MBA from Yale School of Management and a BA in Economics from George Washington University. His prior work experience includes brand management, strategy consulting and finance. Elon lives in Connecticut with his wife, newborn daughter, and very shaggy dog.
Follow Elon Boms:
About LaunchCapital: LaunchCapital was founded in January 2008 with a mission to help entrepreneurs gain quick access to seed capital and mentorship.
